# Evaluation of 3DCRT Versus IGRT and Analysis of Early Response in Head and Neck Cancer.

> **NCT01124409** · PHASE3 · UNKNOWN · sponsor: **All India Institute of Medical Sciences** · enrollment: 41 (actual)

## Conditions studied

- HEAD AND NECK CANCER
- CARCINOMA OROPHARYNX
- CARCINOMA PYRIFORM SINUS
- CARCINOMA LARYNX

## Interventions

- **RADIATION:** EPID Verification
- **RADIATION:** CBCT verification

## Key facts

- **NCT ID:** NCT01124409
- **Lead sponsor:** All India Institute of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-12
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2011-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01124409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01124409, "Evaluation of 3DCRT Versus IGRT and Analysis of Early Response in Head and Neck Cancer.". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT01124409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*